Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Replication of a rare risk haplotype on 1p36.33 for autism spectrum disorder

Abstract

Hundreds of genes have been implicated in autism spectrum disorders (ASDs). In genetically heterogeneous conditions, large families with multiple affected individuals provide strong evidence implicating a rare variant, and replication of the same variant in multiple families is unusual. We previously published linkage analyses and follow-up exome sequencing in seven large families with ASDs, implicating 14 rare exome variants. These included rs200195897, which was transmitted to four affected individuals in one family. We attempted replication of those variants in the MSSNG database. MSSNG is a unique resource for replication of ASD risk loci, containing whole genome sequence (WGS) on thousands of individuals diagnosed with ASDs and family members. For each exome variant, we obtained all carriers and their relatives in MSSNG, using a TDT test to quantify evidence for transmission and association. We replicated the transmission of rs200195897 to four affected individuals in three additional families. rs200195897 was also present in three singleton affected individuals, and no unaffected individuals other than transmitting parents. We identified two additional rare variants (rs566472488 and rs185038034) transmitted with rs200195897 on 1p36.33. Sanger sequencing confirmed the presence of these variants in the original family segregating rs200195897. To our knowledge, this is the first example of a rare haplotype being transmitted with ASD in multiple families. The candidate risk variants include a missense mutation in SAMD11, an intronic variant in NOC2L, and a regulatory region variant close to both genes. NOC2L is a transcription repressor, and several genes involved in transcription regulation have been previously associated with ASDs.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, Chakravarti A et al (2015) A global reference for human genetic variation. Nature 526:68

  2. American Psychiatric Association (2013) Diagnostic and statistical manual, 5th edn. American Psychiatric Association, Washington, DC

  3. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188

  4. Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J et al (2018) Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR 67(1):564–564

  5. Ben-David E, Shifman S (2013) Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol Psychiatry 18:1054–1056

  6. Berg JM, Geschwind DH (2012) Autism genetics: searching for specificity and convergence. Genome Biol 13:247

  7. Bernier R, Gerdts J, Munson J, Dawson G, Estes A (2012) Evidence for broader autism phenotype characteristics in parents from multiple-incidence autism families. Autism Res 5:13–20

  8. Bernier R, Golzio C, Xiong B, Stessman HA, Coe BP et al (2014) Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158:263–276

  9. Bolton PF, Carcani-Rathwell I, Hutton J, Goode S, Howlin P et al (2011) Epilepsy in autism: features and correlates. Br J Psychiatry 198:289–294

  10. Brunham LR, Hayden MR (2013) Hunting human disease genes: lessons from the past, challenges for the future. Hum Genet 132:603–617

  11. Buescher AV, Cidav Z, Knapp M, Mandell DS (2014) Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 168:721–728

  12. Chapman NH, Nato AQ Jr, Bernier R, Ankenman K, Sohi H et al (2015) Whole exome sequencing in extended families with autism spectrum disorder implicates four candidate genes. Hum Genet 134:1055–1068

  13. Constantino JN (2012) Social responsiveness scale, 2nd edn. Western Psychological Services, Los Angeles

  14. Cotney J, Muhle RA, Sanders SJ, Liu L, Willsey AJ et al (2015) The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat Commun 6:6404

  15. Cukier HN, Dueker ND, Slifer SH, Lee JM, Whitehead PL et al (2014) Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol Autism 5:1

  16. Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A et al (2010) Identifying a high fraction of the human genome to be under selective constraint using GERP plus. Plos Comput Biol 6:e1001025

  17. De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K et al (2014) Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515:209–215

  18. Dunn LM, Dunn DM (2007) Peabody picture vocabulary test, 4th edn. American Guidance Service, New York

  19. Dykens EM, Lense M (2011) Intellectual disabilities and autism spectrum disorder: a cautionary note. In: Amaral D, Dawson G, Geschwind DH (eds) Autism spectrum disorders. Oxford University Press, New York, pp 263–270

  20. Felsenstein J, Churchill GA (1996) A hidden Markov Model approach to variation among sites in rate of evolution. Mol Biol Evol 13:93–104

  21. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M et al (2011) Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70:898–907

  22. Gratten J, Visscher PM, Mowry BJ, Wray NR (2013) Interpreting the role of de novo protein-coding mutations in neuropsychiatric disease. Nat Genet 45:234–238

  23. Harrison P, Oakland T (2008) Adaptive behavior assessment system®, 2nd edn. MHS Assessments, Toronto

  24. Hublitz P, Kunowska N, Mayer UP, Muller JM, Heyne K et al (2005) NIR is a novel INHAT repressor that modulates the transcriptional activity of p53. Genes Dev 19:2912–2924

  25. Jin GR, Long CD, Liu WW, Tang Y, Zhu YJ et al (2013) Identification and characterization of novel alternative splice variants of human SAMD11. Gene 530:215–221

  26. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH et al (2002) The human genome browser at UCSC. Genome Res 12:996–1006

  27. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM et al (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46:310

  28. Kozma P, Hughbanks-Wheaton DK, Locke KG, Fish GE, Gire AI et al (2005) Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene. Am J Ophthalmol 140:858–867

  29. Krumm N, O’Roak BJ, Shendure J, Eichler EE (2014) A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 37:95–105

  30. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285

  31. Lin MY, Pedrosa E, Shah A, Hrabovsky A, Maqbool S et al (2011) RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. Plos One 6:e23356

  32. Lord C, Rutter M, DiLavore P, Risi S (1999) Autism diagnostic observation schedule. Western Psychological Services, Los Angeles

  33. Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL et al (2000) The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30:205–223

  34. Lord C, Rutter M, DiLavore PC, Risi S (2003) Autism diagnostic observation schedule manual. Western Psychological Services, Los Angeles

  35. Neale BM, Kou Y, Liu L, Ma’ayan A, Samocha KE et al (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485:242–245

  36. O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N et al (2012) Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246–250

  37. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N et al (2011) Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 128:e488–e495

  38. Piven J, Palmer P, Jacobi D, Childress D, Arndt S (1997) Broader autism phenotype: evidence from a family history study of multiple-incidence autism families. Am J Psychiatry 154:185–190

  39. Power RA, Kyaga S, Uher R, MacCabe JH, Langstrom N et al (2013) Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. Jama Psychiatry 70:22–30

  40. Roid GH (2005) Stanford-binet intelligence scales, 5th edn. Western Psychological Services, Los Angeles

  41. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K et al (2013) ENCODE data in the UCSC genome browser: year 5 update. Nucleic Acids Res 41:D56–D63

  42. Rutter M, LeCouteur A, Lord C (2003) Autism diagnostic interview revised: WPS edition manual. Western Psychological Services, Los Angeles

  43. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT et al (2011) Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70:863–885

  44. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ et al (2012) De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237–241

  45. Shi R, Redman P, Ghose D, Liu Y, Ren XB et al (2017) Shank proteins differentially regulate synaptic transmission. Eneuro 4:163

  46. Silverman JL, Yang M, Lord C, Crawley JN (2010) Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11:490–502

  47. Singh P, Schimenti JC, Bolcun-Filas E (2015) A mouse geneticist’s practical guide to CRISPR applications. Genetics 199:1–15

  48. Sparrow S, Cichetti D, Balla D (2005) Vineland adaptive behavior scales, 2nd edn. Pearson, Bloomington

  49. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506–516

  50. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P et al (2015) Tissue-based map of the human proteome. Science 347:1260419

  51. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R et al (2007) Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 35:W71–W74

  52. Villanueva A, Willer JR, Bryois J, Dermitzakis ET, Katsanis N et al (2014) Whole exome sequencing of a dominant retinitis pigmentosa family identifies a novel deletion in PRPF31. Invest Ophthalmol Vis Sci 55:2121–2129

  53. Wechsler D (1981) Wechsler adult intelligence scale—revised (WAIS-R). Psychological Corporation, New York

  54. Wechsler D (1989) WPPSI-R manual: Wechsler preschool and primary scale of intelligence, revised. Psychological Corporation, New York

  55. Wechsler D (1992) Wechsler intelligence scale for children—third edition (WISC-III). Psychological Corporation, New York

  56. Yu XP, Shi W, Cheng LL, Wang YF, Chen D et al (2016) Identification of a rhodopsin gene mutation in a large family with autosomal dominant retinitis pigmentosa. Sci Rep 6:19759

  57. Yuen RKC, Merico D, Bookman M, Howe JL, Thiruvahindrapuram B et al (2017) Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat Neurosci 20:602

  58. Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D et al (2018) Ensembl 2018. Nucleic Acids Res 46:D754–D761

Download references

Acknowledgements

This study was supported by National Institute of Mental Health Grant R01MH094293. We greatly appreciate the time and effort given by the family members who participated in both our local study and the MSSNG database. The authors also wish to acknowledge the resources of MSSNG (http://www.mss.ng), Autism Speaks and The Centre for Applied Genomics at The Hospital for Sick Children, Toronto, Canada. We thank the donors who supported this program for their generosity.

Author information

Correspondence to Ellen M. Wijsman.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chapman, N.H., Bernier, R.A., Webb, S.J. et al. Replication of a rare risk haplotype on 1p36.33 for autism spectrum disorder. Hum Genet 137, 807–815 (2018). https://doi.org/10.1007/s00439-018-1939-3

Download citation